Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Jake R. Morgan"'
Autor:
Sarah E. Rowan, Jason Haukoos, Kevin F. Kamis, Emily Hopkins, Stephanie Gravitz, Carolynn Lyle, Alia A. Al-Tayyib, Edward M. Gardner, James W. Galbraith, Yu-Hsiang Hsieh, Michael S. Lyons, Richard E. Rothman, Douglas A. E. White, Jake R. Morgan, Benjamin P. Linas, Allison L. Sabel, David L. Wyles, for The DETECT Hep C Trials Investigators
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-9 (2023)
Abstract Background Hepatitis C (HCV) poses a major public health problem in the USA. While early identification is a critical priority, subsequent linkage to a treatment specialist is a crucial step that bridges diagnosed patients to treatment, cure
Externí odkaz:
https://doaj.org/article/3ce5f8e4033e427b86c9a6144af9bf60
Autor:
Jason S. Haukoos, Sarah E. Rowan, James W. Galbraith, Richard E. Rothman, Yu-Hsiang Hsieh, Emily Hopkins, Rachel A. Houk, Matthew F. Toerper, Kevin F. Kamis, Jake R. Morgan, Benjamin P. Linas, Alia A. Al-Tayyib, Edward M. Gardner, Michael S. Lyons, Allison L. Sabel, Douglas A. E. White, David L. Wyles, for The DETECT Hep C Trials Investigators
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Early identification of HCV is a critical health priority, especially now that treatment options are available to limit further transmission and provide cure before long-term sequelae develop. Emergency departments (EDs) are impor
Externí odkaz:
https://doaj.org/article/84b4fb7f3cad4f76a859d487510f432e
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
To explore the impact on timely series completion of initiating the HPV vaccine series prior to other vaccines in the adolescent platform (Tdap or meningococcal vacccines), we created a cohort of children aged 9 in 2015 who were continuously enrolled
Externí odkaz:
https://doaj.org/article/10a69a24f14a4709a033e4cb229ce953
Autor:
Jake R. Morgan, Christina E. Freibott, Ali Jalali, Philip J. Jeng, Alexander Y. Walley, Avik Chatterjee, Traci C. Green, Michelle L. Nolan, Benjamin P. Linas, Brandon D.L. Marshall, Sean M. Murphy
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 4, Iss , Pp 100083- (2022)
Background: Naloxone distributed to people at risk for opioid overdose has been associated with reduced overdose death rates; however, associations of retail pharmacy-distributed naloxone with overdose mortality have not been evaluated. Methods: Our
Externí odkaz:
https://doaj.org/article/75b6ff6dd2ef48bb859449b6db65631a
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss S1, Pp 117-127 (2017)
Abstract Background Hepatitis C virus (HCV) infection represents a major public health burden with diverse epidemics worldwide, but at present, only a minority of infected persons have been tested and are aware of their diagnosis. The advent of highl
Externí odkaz:
https://doaj.org/article/d58d1b45e65c4fb8a7cc72e1b73bdbc9
Publikováno v:
Journal of Occupational & Environmental Medicine. 64:899-904
We aimed to estimate absenteeism due to substance use disorder among full-time employees.We used the 2018 National Survey on Drug Use and Health to identify a sample of individuals employed full time. We used a survey-weighted multivariable negative
Autor:
Rachel L. Epstein, Jianing Wang, Laura F. White, Shashi N. Kapadia, Jake R. Morgan, Yuhua Bao, Benjamin P. Linas
Publikováno v:
American Journal of Preventive Medicine. 63:e87-e98
A total of 23 state Medicaid programs continue to restrict hepatitis C virus (HCV) medication access by liver disease or substance-use criteria, creating obstacles to HCV elimination and significant care disparities. Because public insurers often set
Underscreening, Overscreening, and Guideline-Adherent Cervical Cancer Screening in a National Cohort
Publikováno v:
Obstetrical & Gynecological Survey. 78:103-105
To explore rates of under- and overscreening for cervical cancer among a national cohort.The MarketScan database, a national administrative database of employee-sponsored insurance, was queried for elements relevant to cervical cancer screening among
Autor:
Alexandra Savinkina, Rajapaksha W.M.A. Madushani, Golnaz Eftekhari Yazdi, Jianing Wang, Joshua A. Barocas, Jake R. Morgan, Sabrina A. Assoumou, Alexander Y. Walley, Benjamin P. Linas, Sean M. Murphy
Publikováno v:
Addiction. 117:2450-2461
Medications for opioid use disorder (MOUD) are shown to reduce opioid use and the risk of overdose. People with opioid use disorder (OUD) who exit inpatient medically managed withdrawal programs (detox) without initiating MOUD and linking to outpatie
Autor:
Jake R, Morgan, Emily K, Quinn, Christine E, Chaisson, Elizabeth, Ciemins, Nikita, Stempniewicz, Laura F, White, Benjamin P, Linas, Alexander Y, Walley, Marc R, LaRochelle
Publikováno v:
Med Care
BACKGROUND: The association between cost-sharing and receipt of medication for opioid use disorder (MOUD) is unknown. METHODS: We constructed a cohort of 10,513 commercially insured individuals with a new diagnosis of opioid use disorder (OUD) and in